LifePoint Health, Inc. announced unaudited consolidated earnings and operating results for the third quarter and nine months ended September 30, 2018. For the quarter, the company reported revenue was $1,557 million against $1,576 million a year ago. Income before income taxes was $3.9 million against $55.2 million a year ago. Net income attributable to the company was $22.3 million against $27.5 million a year ago. Diluted earnings per share were $0.56 against $0.67 a year ago. Net cash provided by operating activities was $162.9 million against $91.1 million a year ago. Purchases of property and equipment were $105.6 million against $108.5 million a year ago. Normalized net income was $50.3 million against $34.9 million a year ago. Normalized diluted earnings per share were $1.24 against $0.80 a year ago. Adjusted EBITDA was $161.7 million against $176.0 million a year ago. Normalized EBITDA was $183.3 million against $176.0 million a year ago.

For the nine months, the company reported revenue was $4,729.6 million against $4,801 million a year ago. Income before income taxes was $72.9 million against $221.6 million a year ago. Net income attributable to the company was $65.9 million against $129.9 million a year ago. Diluted earnings per share were $1.66 against $3.16 a year ago. Net cash provided by operating activities was $398.3 million against $293.4 million a year ago. Purchases of property and equipment were $243.2 million against $266.2 million a year ago. Normalized net income was $153.9 million against $128.0 million a year ago. Normalized diluted earnings per share were $3.71 against $2.87 a year ago. Adjusted EBITDA was $537.2 million against $563.8 million a year ago. Normalized EBITDA was $558.8 million against $563.8 million a year ago. This decrease was primarily the result of the recognition of $9.4 million less in Medicare and Medicaid electronic health record (“EHR”) incentive income during the nine months ended September 30, 2018, compared to the same period last year.

For the quarter, the company reported on consolidated basis, number of hospital campuses of 68 against 72 a year ago. Admissions was 63,118 against 66,199 a year ago. Equivalent admissions was 170,801 against 177,475 a year ago. Revenues per equivalent admission was $9,116 against $8,880 a year ago. Total surgeries was 82,778 against 85,982 a year ago. Emergency room visits was 377,356 against 415,119 a year ago. Net revenue days outstanding (days) was 48.4 against 53.4 a year ago. On same hospital basis, number of hospital campuses of 68 against 68 a year ago. Admissions was 62,579 against 62,533 a year ago. Equivalent admissions was 169,214 against 168,026 a year ago. Revenues per equivalent admission was $9,151 against $9,024 a year ago. Total surgeries was 82,122 against 82,076 a year ago. Emergency room visits was 372,981 against 387,774 a year ago. Net revenue days outstanding (days) was 48.8 against 53.6 a year ago.

For the nine months, the company reported on consolidated basis, number of hospital campuses of 68 against 72 a year ago. Admissions was 193,268 against 202,215 a year ago. Equivalent admissions was 516,219 against 535,061 a year ago. Revenues per equivalent admission was $9,162 against $8,973 a year ago. Total surgeries was 252,733 against 260,536 a year ago. Emergency room visits was 1,155,839 against 1,254,092 a year ago. Net revenue days outstanding (days) was 48.4 against 53.4 a year ago. On same hospital basis, number of hospital campuses of 68 against 68 a year ago. Admissions was 189,481 against 191,182 a year ago. Equivalent admissions was 504,967 against 506,823 a year ago. Revenues per equivalent admission was $9,244 against $9,118 a year ago. Total surgeries was 248,066 against 248,409 a year ago. Emergency room visits was 1,124,445 against 1,171,607 a year ago. Net revenue days outstanding (days) was 48.8 against 53.6 a year ago.

For the 2018 third quarter, the company reported impairment losses was $23.0 million against $13.4 million a year ago.